• A diagnostic dilemma: distinguishing a sulfasalazine induced DRESS hypersensitivity syndrome from a CD30 + lymphoma in a young patient
• A World without Measles and Rubella: Addressing the Challenge of Vaccine Hesitancy
• Accelerating Global Measles and Rubella Eradication-Saving Millions of Lives, Preventing Disability, and Averting the Next Pandemic
• Acquired Cytomegalovirus Retinitis in Preterm Infant Hospitalized in the NICU: A Noteworthy Case Report
• Adapting response to a measles outbreak in a context of high vaccination and breakthrough cases: an example from Vaud, Switzerland, January to March 2024
• Addressing the Dangerous Consequences of the Resurgence of Measles and Rubella: The Critical Need for a Global Target
• Altered interactions between cis-regulatory elements partially resolve BLADE-ON-PETIOLE genetic redundancy in Capsella rubella
• Anti-rubella IgG serum levels predict risk for SARS-CoV-2 breakthrough infections
• Anti-Rubella Immunoglobulin G Proficiency Testing Results Suggest Consistent Manufacturer Differences and Opportunity for Harmonization
• Antibacterial activities of Adina rubella extract enhanced by fermentation and its application in packaging films
• Antiviral action of aqueous extracts of propolis from Scaptotrigona aff. postica (Hymenoptera; Apidae) against Zica, Chikungunya, and Mayaro virus
• Antiviral and Immunomodulatory Effects of Interferon Lambda at the Maternal-Fetal Interface
• Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella
• Assessing clinical benefits of live-attenuated vaccination in post-liver transplant patients: Analysis of breakthrough infections and natural boosters
• Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory
• Assessing the impact of COVID-19 on routine immunization in Sierra Leone
• Challenges for Sustaining Measles Elimination: Post-Verification Large-Scale Import-Related Measles Outbreaks in Mongolia and Cambodia, Resulting in the Loss of Measles Elimination Status
• Characterizing timeliness of recommended vaccinations among privately-insured children in the United States, 2009-2019
• Childhood vaccination trends during 2019 to 2022 in Tanzania and the impact of the COVID-19 pandemic
• Co-circulation of two Alphaviruses in Burkina Faso: Chikungunya and O'nyong nyong viruses
• Comparison of Congenital Rubella Syndrome Cases at a Philippine Tertiary Hospital from 2009-2012 to 2019-2022
• Congenital papulovesicular eruption mimicking TORCH syndrome in newborn
• Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine
• Congenital rubella syndrome, a case series
• Congenital Rubella Syndrome: A Case Report from Somalia
• Cost-Effectiveness Analysis of Routine Outreach and Catch-Up Campaign Strategies for Measles, Mumps, and Rubella Vaccination in Chuuk, Federated States of Micronesia
• Cytokine Storm Syndrome Associated with Hemorrhagic Fever and Other Viruses
• Development of an indirect ELISA for detecting Toxoplasma gondii IgG antibodies based on a recombinant TgIMP1 protein
• Economic evaluation of second measles containing vaccine (MCV) dose: a systematic review of available evidence
• Environmental Signals
• Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program
• Evaluation of T. gondii, rubella, and cytomegalovirus seroprevalences among female Syrian refugees in Sanliurfa, Turkiye
• Evaluation of the AltoStar AM16 system for the quantitation of AdV, CMV and HHV-6 DNA from clinical specimens
• Evolution and Contribution of a Global Partnership against Measles and Rubella, 2001-2023
• Exanthematous Eruption in a Patient With Known Chronic Graft-vs-Host Disease and Recent Measles Vaccination
• Family Structure Associated with Measles-Rubella and Varicella Vaccination in Children
• Feasibility and acceptability of collecting dried blood spots (DBS) from children after vaccination during supplementary immunization activities to estimate measles and rubella seroprevalence
• Feasibility, performances and predictive value of congenital CMV neonatal screening on saliva swabs
• Genomic, transcriptomic, and metabolomic analyses provide insights into the evolution and development of a medicinal plant <em>Saposhnikovia divaricata</em> (Apiaceae)
• Global and regional burden of vaccine-associated facial paralysis, 1967-2023: Findings from the WHO international pharmacovigilance database
• Global and regional burden of vaccine-induced thrombotic thrombocytopenia, 1969-2023: Comprehensive findings with critical analysis of the international pharmacovigilance database
• Global burden of vaccine-associated hepatobiliary and gastrointestinal adverse drug reactions, 1967-2023: A comprehensive analysis of the international pharmacovigilance database
• Global Update on Measles Molecular Epidemiology
• Health and Economic Benefits of Routine Childhood Immunizations in the Era of the Vaccines for Children Program - United States, 1994-2023
• How to prevent rubella epidemics and congenital rubella syndrome: lessons from 42 years of longitudinal epidemiology in Osaka Prefecture, Japan (1982-2023)
• Human DNA-dependent protein kinase catalytic subunit deficiency: a comprehensive review and update
• Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study
• Immunity against vaccine-preventable diseases among pregnant employees in Germany. A situation analysis before the introduction of the Measles Protection Act
• Infectious diseases in Poland in 2021
• Information and vaccine hesitancy: The role of broadband Internet
• Investigating the relationship between health literacy and preconceptual care components during the first 14 weeks of pregnancy: a cross-sectional study
• Investigation of atypical serological profiles for Epstein-Barr virus (EBV)
• Live Vaccine and Varicella Postexposure Prophylaxis in Pediatric Liver Transplant Recipients: A Survey of Practice in Australia and New Zealand
• Long-term persistence of seroprotection against measles following measles-mumps-rubella vaccination administered before and after pediatric liver transplantation
• Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries
• Measles and Rubella Elimination in the Western Pacific Region in 2013-2022: Lessons Learned from Progress and Achievements Made during Regional and Global Measles Resurgences
• Measles in the vaccinated host
• Measles outbreak in 2019: a warning for the post-COVID-19 pandemic period
• Medium-term storage of frozen residual antenatal sera in gel separator tube is suitable for subsequent serological investigation of intrauterine infection
• Microneedle Vaccine Patches Generated Immune Response in Children
• Mumps in Poland in 2021
• Natural Language Processing-Powered Real-Time Monitoring Solution for Vaccine Sentiments and Hesitancy on Social Media: System Development and Validation
• Navigating Pakistan's immunization landscape: Progress and pitfalls
• Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study
• Phase III, open-label, single-arm study of a new MMR vaccine (JVC-001); measles AIK-C, mumps RIT 4385, rubella Takahashi, as a second vaccine dose in healthy Japanese children aged 5-6 years
• Possible counter-intuitive impact of local vaccine mandates for vaccine-preventable infectious diseases
• Progress and Challenges in Measles and Rubella Elimination in the WHO European Region
• Questionable Immunity to Mumps among Healthcare Workers in Italy-A Cross-Sectional Serological Study
• Raising Epidemiological Awareness: Assessment of Measles/MMR Susceptibility in Highly Vaccinated Clusters within the Hungarian and Croatian Population-A Sero-Surveillance Analysis
• Recent Surge in Mumps Cases in India: Will the Introduction of the MMR Vaccine Prevent Future Outbreaks?
• Rubella immunity among pregnant women and the burden of congenital rubella syndrome (CRS) in India, 2022
• Rubella in Poland in 2021
• Rubella virus might increase risk of MS
• Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis
• Rubella virus-associated granulomas controlled with allogeneic hematopoietic stem cell transplantation
• Safety and 6-month immune persistence of inactivated poliovirus vaccine (Sabin strains) simultaneously administrated with other vaccines for primary and booster immunization in Jiangxi Province, China
• Screening for TORCH Antibodies in Croatian Childbearing-Aged Women, 2014-2023
• Secondary Glaucoma after Cataract Surgery performed in Infancy in Congenital Rubella Syndrome -A Case Control Study
• Selection of DNA aptamer for label-free electrochemical aptasensor for the detection of rubella virus
• Seroepidemiology of measles and rubella among Hong Kong young adults and the humoral responses of an MMR booster among participants with low antibody levels
• Serological responses to vaccination in children exposed in utero to ustekinumab or vedolizumab: cross-sectional analysis of a prospective multicentre cohort
• Seroprevalence status of vaccine-preventable diseases in migrants living in shelter centers in Barcelona, Spain
• Serosurveillance for Measles and Rubella
• Serum signature of antibodies to Toxoplasma gondii, rubella virus, and cytomegalovirus in females with bipolar disorder: A cross-sectional study
• Shedding of measles vaccine RNA in children after receiving measles, mumps and rubella vaccination
• Successful Elimination of Endemic Rubella in the WHO European Region. Is It Proper to Remove the Recommendation for Preconceptional Immunization?
• Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019-2023: From Challenges to Opportunities
• Technology versus nostalgia; A randomized controlled trial of the effect of virtual reality and kaleidescop on pediatric pain, fear and anxiety management during immunization
• The impact of sub-national heterogeneities in demography and epidemiology on the introduction of rubella vaccination programs in Nigeria
• The impact of temperature, humidity and closing school on the mumps epidemic: a case study in the mainland of China
• Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective
• Timeliness of Childhood Vaccinations Following Strengthening of the Second Year of Life (2YL) Immunization Platform and Introduction of Catch-Up Vaccination Policy in Ghana
• Vaccination Week in the Americas: An Ongoing Initiative to Strengthen and Sustain Measles and Rubella Elimination in the Region
• Vital Signs: Trends and Disparities in Childhood Vaccination Coverage by Vaccines for Children Program Eligibility - National Immunization Survey-Child, United States, 2012-2022
• Waning of Humoral Immunity to Vaccine-Preventable Diseases in Children Treated for Acute Lymphoblastic Leukemia: A Single-Center Retrospective Cross-Sectional Analysis
• Wells syndrome following vaccination: A pediatric case with positive patch test to gelatin
• Williams-Beuren syndrome diagnosis in an infant with atypical chromosome 7 microdeletion
• Worth a Shot: Experience and Lessons From an Unsuccessful Pediatric Immunization Quality Improvement Effort in a Large Health System During the COVID-19 Pandemic
• Wrongful birth and wrongful life lawsuits in obstetrics and gynecology
• Zika virus as a new pathogenic agent within the Toxoplasma gondii, Rubella virus, Cytomegalovirus, and Herpes simplex (TORCH) virus family: where do we stand?